Related Experiment Video

Updated: May 29, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Hot-topic debate on kidney function: renal-sparing approaches are ineffective

John R Lake1

  • 1Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN 55455, USA. lakex009@umn.edu

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|September 8, 2011
PubMed
Abstract

Insights

Kidney disease is common after liver transplants, impacting long-term success. While calcineurin inhibitors (CNIs) are essential early on, their role in chronic renal failure may be overstated, necessitating research into new immunosuppressants.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Immunology

Background:

  • Acute kidney injury and chronic renal disease frequently affect liver transplant recipients.
  • The diverse etiologies of renal complications necessitate comprehensive understanding.

Purpose of the Study:

  • To evaluate the incidence and impact of renal disease post-liver transplantation.
  • To assess the role of calcineurin inhibitors (CNIs) in the development of chronic renal failure.
  • To explore the potential of novel immunosuppressive agents.

Main Methods:

  • Review of patient data and clinical outcomes following liver transplantation.
  • Analysis of renal function markers and immunosuppressive drug regimens.
  • Comparative assessment of different immunosuppressive strategies.

Main Results:

  • High incidence of acute kidney injury and chronic renal disease observed in liver transplant patients.
  • Chronic renal failure significantly compromises long-term outcomes.
  • The contribution of CNIs to chronic renal failure appears potentially overestimated.

Conclusions:

  • Calcineurin inhibitors are critical in the early post-transplant phase.
  • The long-term renal impact of current immunosuppression requires further investigation.
  • Efficacy of new immunosuppressive agents as primary therapy is yet to be established.

More Related Videos

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...